47 related articles for article (PubMed ID: 2843131)
1. Efficacy of Combined Regional Inductive Moderate Hyperthermia and Chemotherapy in Patients With Multiple Liver Metastases From Breast Cancer.
Klimanov MY; Syvak LA; Orel VE; Lavryk GV; Tarasenko TY; Orel VB; Rykhalskyi AY; Stegnii VV; Nesterenko AO
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806003. PubMed ID: 30336769
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermia-embolization-immunotherapy: a potent trio in advancing cancer treatment.
Zaman R; Cai X; Shubhra QTH
Trends Mol Med; 2023 Dec; 29(12):976-978. PubMed ID: 37863716
[TBL] [Abstract][Full Text] [Related]
3. [Effects of hyperthermia combined with chemoembolization using degradable starch microspheres in the treatment of hepatocellular carcinoma].
Itani K; Yoshikawa T; Tainaka K; Oyamada Y; Sugino S; Kondo M; Seto O
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1418-22. PubMed ID: 2837995
[TBL] [Abstract][Full Text] [Related]
4. [Chemoembolization with degradable starch microspheres in malignant hepatic tumors].
Itani K; Yoshikawa T; Tainaka K; Naito Y; Seto O; Hotta T; Sugino S; Kondo M
Gan To Kagaku Ryoho; 1987 Feb; 14(2):388-95. PubMed ID: 3028277
[TBL] [Abstract][Full Text] [Related]
5. [Chemoembolization with degradable starch microspheres in metastatic liver cancer].
Itani K; Yoshikawa T; Oyamada Y; Tainaka K; Sugino S; Kondo M
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2606-10. PubMed ID: 3137883
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor effect and indication of chemoembolization using degradable starch microspheres and regional hyperthermia in patients with hepatocellular carcinoma].
Yoshikawa T; Oyamada H; Ichikawa H; Naito Y; Ueda S; Tainaka K; Itani K; Seto O; Sugino S; Kondo M
Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):786-92. PubMed ID: 2550568
[TBL] [Abstract][Full Text] [Related]
7. [Chemoembolization with degradable starch microspheres for liver metastases in colorectal cancer].
Itani K; Yoshikawa T; Oyamada H; Takano H; Ichikawa H; Tainaka K; Sugino S; Kondo M
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2897-900. PubMed ID: 2506828
[TBL] [Abstract][Full Text] [Related]
8. [Chemoembolization and regional hyperthermia with degradable starch microspheres in the treatment of malignant hepatic tumors].
Yoshikawa T; Oyamada H; Itani K; Tainaka K; Seto O; Sugino S; Kondo M
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2646-52. PubMed ID: 2843131
[TBL] [Abstract][Full Text] [Related]
9. [Liver tumor targeting of drugs: Spherex, a vascular occlusive agent].
Taguchi T
Gan To Kagaku Ryoho; 1995 Jun; 22(7):969-76. PubMed ID: 7794007
[TBL] [Abstract][Full Text] [Related]
10. [Nonsurgical therapy of focal liver lesions].
Allgaier HP; Deibert P; Blum HE
Praxis (Bern 1994); 1997 Jan; 86(4):86-90. PubMed ID: 9064724
[TBL] [Abstract][Full Text] [Related]
11. [Recent progress in multidisciplinary treatment of hepatic cancer].
Fujita M; Nakamura H; Taguchi T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1000-7. PubMed ID: 2543301
[TBL] [Abstract][Full Text] [Related]
12. [Clinical effectiveness of degradable starch microspheres (DSM) in patients with liver cancer].
Kumada T; Nakano S; Sone Y; Kiriyama S; Hisanaga Y; Rikitoku T; Tamoto A; Honda T
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1678-83. PubMed ID: 10560370
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
